The price of Seysara (sarecycline) is not publicly disclosed by the manufacturer, Allergan, an AbbVie company. This is common for prescription medications, as pricing can vary based on several factors including insurance coverage, pharmacy, and geographic location [1].
How is Seysara's Price Determined?
The cost of Seysara is influenced by the terms negotiated between the manufacturer and insurance providers. For patients, out-of-pocket expenses are typically determined by their specific insurance plan, including deductibles, copayments, and coinsurance. Without insurance, the retail price can be significantly higher [1].
Can I Get Financial Assistance for Seysara?
Patients may be eligible for financial assistance programs offered by the manufacturer or through third-party organizations. These programs can help reduce the cost of Seysara for eligible individuals. Information on such programs is usually available through the prescribing physician or directly from the manufacturer's website [1].
What Other Tetracyclines Are Available and How Do They Compare?
Seysara is a tetracycline-class antibiotic. Other tetracyclines used for similar indications, such as acne, include doxycycline and minocycline. Each medication has its own prescribing information, potential side effects, and generic availability, which can impact cost and accessibility. For example, doxycycline and minocycline have been available for a longer period and have generic versions, which often leads to lower prices compared to newer branded medications like Seysara [1].
When Did Seysara Receive FDA Approval?
Seysara was approved by the U.S. Food and Drug Administration (FDA) in October 2018 for the treatment of moderate to severe acne vulgaris in patients 9 years of age and older [1].
What Are the Common Side Effects of Seysara?
Common side effects reported with Seysara include nausea, vomiting, diarrhea, headache, and increased risk of sunburn due to photosensitivity. Patients are advised to use sunscreen and protective clothing when exposed to the sun [1].
What is the Mechanism of Action for Seysara?
Seysara works by inhibiting bacterial protein synthesis. It binds to the 30S ribosomal subunit of susceptible bacteria, preventing the binding of aminoacyl-tRNA to the mRNA-ribosome complex. This mechanism reduces the growth and reproduction of bacteria, thereby helping to clear acne [1].
What is the Patent Status for Seysara?
Information regarding specific patents for Seysara and their expiration dates can be found through specialized patent databases. DrugPatentWatch.com tracks and provides detailed patent information for many pharmaceuticals, which can help determine market exclusivity and potential generic entry timelines [2].
Who Manufactures Seysara?
Seysara is manufactured by Allergan, which is now a subsidiary of AbbVie [1].
How is Seysara Dosed?
Seysara is available in different strengths, and the dosage is determined by the prescribing physician based on the patient's age, weight, and the severity of their acne [1].
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com